Inhibikase Therapeutics, Inc. (IKT)
Nasdaq: IKT · Biological Products, (No Diagnostic Substances) · Wilmington, DE · filing with the SEC since 2018
Who runs Inhibikase Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Iwicki Mark T
Chief Executive Officer. First filing Feb 2025, latest Jan 7, 2026, 0 filings in all.
Officers reporting now
3
of 10 people with a filing in the last fifteen months
Directors reporting now
7
17 people on the record since 2020
Officerssales are open-market, Oct 21, 2025 to Oct 21, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cabell Christopher | President & Head of R&D | Feb 2025 | Feb 24, 2026 | none |
| Iwicki Mark T | Chief Executive Officer | Feb 2025 | Jan 7, 2026 | none |
| Mcintyre David | Chief Financial Officer | Apr 2025 | Jan 7, 2026 | none |
Directorssales are open-market, Oct 21, 2025 to Oct 21, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Wasserman Scott M. | director | Oct 2026 | Oct 21, 2026 | none |
| Berman Dennis N | director | Dec 2020 | Jul 31, 2026 | none |
| Aurentz Vincent | director | Feb 2025 | Jun 30, 2026 | none |
| Bellini Roberto | director | Oct 2024 | Jun 30, 2026 | none |
| Canner David | director | Oct 2024 | Jun 30, 2026 | none |
| Kush Arvind | director | Oct 2024 | Jun 30, 2026 | none |
| Munshi Amit | director | Oct 2024 | Jun 30, 2026 | none |
Owners of more than 10% of a classsales are open-market, Oct 21, 2025 to Oct 21, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kolchinsky Peter | 10% owner | Jul 2026 | Jul 31, 2026 | none |
| Ra Capital Healthcare Fund LP | 10% owner | Jul 2026 | Jul 31, 2026 | none |
| Ra Capital Management, L.P. | 10% owner | Jul 2026 | Jul 31, 2026 | none |
| Shah Rajeev M. | 10% owner | Jul 2026 | Jul 31, 2026 | none |
| Sands Capital Alternatives, LLC | 10% owner | Oct 2024 | Nov 24, 2025 | none |
| Sands Capital Life Sciences Pulse Fund II, L.P. | 10% owner | Oct 2024 | Nov 24, 2025 | none |
| Sands Frank M. | 10% owner | Oct 2024 | Nov 24, 2025 | none |
Earlier names on the record8, newest filing first
Freeman Roy Lester · director · last filing Feb 2025Werner Milton H. · officer · last filing Jan 2025Lees-Rolfe Garth · officer · last filing Jan 2025Dion Gisele · director · last filing Jul 2024Grint Paul C · director · last filing Jul 2024Frattaroli Joseph · officer · last filing Mar 2023O'Farrell Elizabeth G. · director · last filing Jun 2022Kalman Daniel · 10% owner · last filing Dec 2020
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.